共 50 条
WHOLE-BODY F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN PREOPERATIVE EVALUATION OF LUNG-CANCER
被引:176
|作者:
LEWIS, P
GRIFFIN, S
MARSDEN, P
GEE, T
NUNAN, T
MALSEY, M
DUSSEK, J
机构:
[1] GUYS & ST THOMAS HOSP TRUST,CTR CLIN POSITRON ELECTRON TOMAG,LONDON,ENGLAND
[2] GUYS & ST THOMAS HOSP TRUST,DEPT CARDIOTHORAC SURG,LONDON,ENGLAND
来源:
LANCET
|
1994年
/
344卷
/
8932期
关键词:
D O I:
10.1016/S0140-6736(94)90753-6
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Despite use of computed tomography, some lung cancer patients are found to have unresectable disease at surgery, or they present early with metastases. We studied whether whole-body -positron emission tomography (PET) with F-18-fluorodeoxyglucose ((18)FDG) would improve the preoperative detection of metastases. We retrospectively analysed 34 patients with ''operable'' non-small-cell lung cancer who underwent (18)FDG PET after routine assessment. Management changes produced by the PET scan and confirmatory tests were reviewed. PET unsuspected malignant lesions in 10 (29%) Management changes occurred in 14 (41%), including 6 (18%) patients who were changed to non-surgical therapy. These data suggest that whole-body (18)FDG PET improves preoperative assessment of lung cancer patients.
引用
收藏
页码:1265 / 1266
页数:2
相关论文